Xu Zhenyu sold $30K of SOPH
Xu Zhenyu (Chief Scientific Officer) sold 4,000 shares of SOPHiA GENETICS SA (SOPH) at $7.52 on 2026-08-13 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed sale details: 4,000 shares sold at $7.5191 for about $30.1k, with post-transaction holdings of 586,887 shares, under a 10b5-1 plan.
Market read
Traders may note the insider sale, but there is no accompanying fundamental catalyst in the text.
What to watch
The article does not state whether other insiders sold, whether the company has concurrent news, or whether the sale size is unusual versus prior patterns.
Background
The article is an SEC Form 4 insider transaction disclosure for SOPHiA GENETICS SA, reported by its Chief Scientific Officer.
Ticker impact
SOPHiA GENETICS disclosed a Form 4 showing CSO Xu Zhenyu sold 4,000 shares at $7.5191 on 2026-08-13 under a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely limited and short-lived.
The filing is a routine 10b5-1 open-market sale with no accompanying operational, financial, or regulatory catalyst described in the text.
Market effects
No sector-level implications are provided; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.
Key entities
- issuerSOPHiA GENETICS SA
Subject of the Form 4 insider transaction disclosure.
- insiderXu Zhenyu
Chief Scientific Officer who executed the open-market sale under a 10b5-1 plan.
